|
Market Closed -
NSE India S.E.
07:12:08 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 573.25 INR | +0.12% |
|
-2.16% | -18.69% |
| 07-31 | Astec LifeSciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 04-27 | Astec LifeSciences March-quarter consol net loss 77.6 million rupees | RE |
Company Valuation: Astec LifeSciences Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 34,391 | 27,154 | 20,932 | 13,243 | 12,046 | 12,774 | - | - |
| Change | - | -21.04% | -22.91% | -36.73% | -9.04% | 6.04% | - | - |
| Enterprise Value (EV) | 37,163 | 27,154 | 20,932 | 13,243 | 12,046 | 12,774 | 12,774 | 12,774 |
| Change | - | -26.93% | -22.91% | -36.73% | -9.04% | 6.04% | 0% | 0% |
| P/E | 38.3x | 106x | -44.6x | -9.83x | -14.3x | -45.9x | 52.1x | 19.8x |
| PBR | 8.68x | 6.47x | 5.67x | 5.64x | - | 3.53x | 3.11x | 2.7x |
| PEG | - | -1.5x | 0x | -0x | 0.3x | 0.7x | -0x | 0x |
| Capitalization / Revenue | 5.08x | 4.32x | 4.57x | 3.47x | - | 2.28x | 1.72x | 1.41x |
| EV / Revenue | 0x | 0x | 0x | 0x | - | 2.28x | 1.72x | 1.41x |
| EV / EBITDA | 0x | 0x | -0x | -0x | - | 28.5x | 12.2x | 8.49x |
| EV / EBIT | 0x | 0x | -0x | -0x | - | 24.1x | 16.7x | 10x |
| EV / FCF | -0x | - | - | - | - | -72.2x | -81.4x | 50.9x |
| FCF Yield | -2.34% | - | - | - | - | -1.39% | -1.23% | 1.96% |
| Dividend per Share 2 | 1.5 | 1.5 | - | - | - | 1.5 | 1.25 | 1.25 |
| Rate of return | 0.09% | 0.11% | - | - | - | 0.26% | 0.22% | 0.22% |
| EPS 2 | 45.85 | 13.04 | -23.93 | -68.71 | -37.79 | -12.5 | 11 | 28.9 |
| Distribution rate | 3.27% | 11.5% | - | - | - | -12% | 11.4% | 4.33% |
| Net sales 1 | 6,766 | 6,282 | 4,582 | 3,813 | - | 5,595 | 7,409 | 9,082 |
| EBITDA 1 | 1,541 | 762.5 | -59.13 | -662.1 | - | 448 | 1,044 | 1,504 |
| EBIT 1 | 1,197 | 426 | -421.7 | -1,099 | - | 530 | 767 | 1,276 |
| Net income 1 | 898.6 | 255.6 | -469.3 | -1,348 | -809.2 | -279 | 246 | 644.5 |
| Net Debt | 2,772 | - | - | - | - | - | - | - |
| Reference price 2 | 1,755.25 | 1,385.00 | 1,067.45 | 675.25 | 540.60 | 573.25 | 573.25 | 573.25 |
| Nbr of stocks (in thousands) | 19,593 | 19,606 | 19,609 | 19,611 | 22,282 | 22,283 | - | - |
| Announcement Date | 5/2/22 | 5/2/23 | 5/2/24 | 4/23/25 | 4/27/26 | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -45.8x | - | - | 0.26% | 135M | |
| 35.01x | 3.28x | 14.08x | 0.82% | 60.03B | |
| 10.46x | 1.26x | 6.28x | 4.9% | 8.38B | |
| 15.45x | 1.14x | 5.97x | 1.55% | 5.15B | |
| 31.11x | 4.53x | 19.25x | 0.6% | 3.84B | |
| Average | 9.24x | 2.55x | 11.40x | 1.63% | 15.51B | |
| Weighted average by Cap. | 30.72x | 2.98x | 12.95x | 1.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ASTEC Stock
- Valuation Astec LifeSciences Limited
Select your edition
All financial news and data tailored to specific country editions
